Table 1 Demographic and clinical characteristics and ratio of Blastocystis spp. infections in study and control groups
From: Blastocystosis in patients with gastrointestinal symptoms: a case–control study
Symptomatic Patients | Control group | |||
|---|---|---|---|---|
IBS | IBD | Others | ||
Demographic and clinical characteristics | ||||
Age (years); mean (SD) | 45.8(16.2) | 45.2(13.2) | 47.3(16.1) | 45.5(15.2) |
Gender | ||||
Male% | 39.6 | 41.8 | 44.9 | 42.4 |
Female% | 60.4 | 58.2 | 55.1 | 57.6 |
Clinical Symptoms% | ||||
Abdominal pain | 79.8 | 83.5 | 81.1 | |
Constipation | 50.2 | 14.9 | 49.5 | |
Diarrhea | 34.2 | 89.5 | 48.8 | |
Bloating | 79.8 | 74.6 | 71.3 | |
Flatulence | 50.2 | 59.7 | 54.3 | |
Blastocystis spp. infections | ||||
B. hominis positivity | Total | |||
N | % | N | ||
Total symptomatic patients | 134 | 5.74 | 2334 | |
Symptomatic patients/ undiagnosed | 55 | 4.90 | 1122 | |
IBD | 28 | 8.35 | 335 | |
UC | 24 | 8.70 | 276 | |
CD | 4 | 6.78 | 59 | |
IBS | 51 | 5.82 | 877 | |
Controls | 6 | 3.12 | 192 | |